Single-dose ceftriaxone for chancroid | Zendy

M. Ian Bowmer | Zendy; H Nsanze | Zendy; L J D'Costa | Zendy; Joe Dylewski | Zendy; L Fransen | Zendy; Peter Piot | Zendy; Allan Ronald | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Single-dose ceftriaxone for chancroid

Author(s) -

M. Ian Bowmer,

H Nsanze,

L J D'Costa,

Joe Dylewski,

L Fransen,

Peter Piot,

Allan Ronald

Publication year - 1987

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.31.1.67

Subject(s) - haemophilus ducreyi , chancroid , ceftriaxone , medicine , antibiotics , intramuscular injection , pasteurellaceae , antibacterial agent , sexually transmitted disease , syphilis , microbiology and biotechnology , virology , haemophilus influenzae , biology , human immunodeficiency virus (hiv)

Men with genital ulcers that were culture positive for Haemophilus ducreyi were treated with intramuscular ceftriaxone and randomized to three different dose regimens. All but 1 of 50 men treated with 1 g of intramuscular ceftriaxone were cured. Similarly, 0.5 and 0.25 g cured 43 of 44 men and 37 of 38 men, respectively. A single dose of 250 mg of intramuscular ceftriaxone is an effective treatment for chancroid.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research